Showing results (181-190 of 309) with videos related to
Sort By:
Pageof 31
Journal of Clinical Medicine|January 8, 2023
Upregulation of miRNA-200c during Disease Progression in COVID-19 PatientsLukas van de Sand, Peer Braß, Jonas Gregorius, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2014
Activated CD8+ T cells induce expansion of Vβ5+ regulatory T cells via TNFR2 signalingJara J Joedicke, Lara Myers, Aaron B Carmody, et al.Journal of Innate Immunity|January 15, 2020
SERINC5 Is an Unconventional HIV Restriction Factor That Is Upregulated during Myeloid Cell DifferentiationAriane Zutz, Christian Schölz, Stephanie Schneider, et al.Journal of Virology|June 20, 2024
The interferon-regulated host factor hnRNPA0 modulates HIV-1 production by interference with LTR activity, mRNA trafficking, and programmed ribosomal frameshiftingFabian Roesmann, Helene Sertznig, Katleen Klaassen, et al.Scientific Reports|May 21, 2026
Spheroids reveal hypoxia‑driven spatial restriction of adenoviral infectionTamara Büttner, Xiaoyan Wang, Brenda Krishnacoumar, et al.Retrovirology|September 28, 2011
Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypesWibke Bayer, Ruth Lietz, Teona Ontikatze, et al.Redox Biology|June 30, 2026
Low serum selenium combined with SELENOP-autoantibodies are associated with persistent fatigue after SARS-CoV-2 infectionBörge Schmidt, Sabrina Asaad, Laven Mavarani, et al.Plos Pathogens|October 21, 2015
PD-L1 Expression on Retrovirus-Infected Cells Mediates Immune Escape from CD8+ T Cell KillingIlseyar Akhmetzyanova, Malgorzata Drabczyk, C Preston Neff, et al.Gastroenterology|March 10, 2020
Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naïve to Nucleos(t)ide TherapyMichel Bazinet, Victor Pântea, Gheorghe Placinta, et al.Blood Advances|April 7, 2019
Plasmacytoid dendritic cells respond to Epstein-Barr virus infection with a distinct type I interferon subtype profileCornelia Gujer, Anita Murer, Anne Müller, et al.Pageof 31